ClinicalTrials.Veeva

Menu

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

The University of Tennessee, Knoxville logo

The University of Tennessee, Knoxville

Status

Withdrawn

Conditions

Inflammatory Breast Neoplasms
Inflammatory Breast Cancer Stage IV
Breast Cancer
Triple Negative Breast Neoplasms
Neoplasm Metastasis

Treatments

Behavioral: Self-Administered Hypnosis
Behavioral: Self-Administered White Noise Hypnosis

Study type

Interventional

Funder types

Other

Identifiers

NCT06057636
UTK-IRB-23-07650-XP

Details and patient eligibility

About

The purpose of this study is to compare two hypnotic interventions for Black women with advanced cancer pain in preparation for a well-powered phase III study. The investigators plan to enroll 30 adult Black women with advanced cancer pain in a 2-arm pilot randomized controlled trial (RCT).

The primary aim will be to evaluate the feasibility of conducting the 2-arm clinical trial. It is hypothesized that at least 75% of participants in both study arms will complete study requirements. The secondary aims will be to evaluate the participant's experience with the intervention and to determine the effect size of the intervention on pain severity.

Full description

Envision is a randomized, 2-arm, mixed-methods pilot study to evaluate the feasibility of translating a promising in-person hypnosis intervention for advanced cancer pain into a culturally appropriate, remotely delivered hypnosis intervention for pain in Black women with advanced cancer. The study is 6 weeks long and does not require any in-person visits. If a breast cancer survivor is determined eligible, they will be educated on the purpose, requirements, and procedures. If interested, participants will be emailed the consent form and will schedule a virtual consent/baseline visit. After consent is obtained, the participant will be randomly assigned to one of two types of hypnotic relaxation to be used alongside current pain treatment using 1:1 randomization and given a study number. The participant will complete online surveys at the virtual baseline visit. An MP3 player with hypnotic relaxation audio files will be sent to the participant's address and a virtual education visit will be scheduled. At this second virtual visit, participants will receive education about their study arm and a start date will be agreed upon for week 1. Beginning week 1 and continuing through week 6, participants will listen to their assigned hypnotic relaxation audio files daily and be asked to complete a weekly practice log. Participants will also continue to meet with study staff virtually for weekly check-ins. At these weekly meetings, progress and adverse events will be assessed and relevant online surveys will be completed.

Sex

Female

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18 years of age or older Black female
  2. Diagnosed with Stage IV Breast Cancer with life expectancy of 6 months or more
  3. Ability to read and write English
  4. Ability to complete questionnaire(s) by themselves or with assistance.
  5. Report cancer-related pain that they rate as ≥4 on a numeric pain rating scale of 0-10 with 0 being "no pain" and 10 being "the worst it can be" for the past month or more.
  6. Ability to provide informed written consent.

Exclusion criteria

  1. Diagnosis of major depressive disorder or acute anxiety disorder per the medical record or self-report in the past 2 years
  2. Serious psychological illness, specifically psychoses, schizophrenia, or borderline personality disorder per the medical record or self-report
  3. Currently enrolled in hospice
  4. Currently using hypnosis for any reason
  5. Non-English speaking
  6. Unable to complete questionnaires or follow directions independently.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

Self-Administered Hypnosis
Experimental group
Description:
Self-administered hypnosis will be practiced daily, at home for 6 weeks. Hypnosis sessions are expected to last \~20 minutes. Practices using the recordings will be documented on the Hypnosis Practice Log.
Treatment:
Behavioral: Self-Administered Hypnosis
Self Administered White Noise Hypnosis
Active Comparator group
Description:
Self-administered white noise hypnosis will be practiced daily using a white noise recording. Participants will practice hypnosis at home after completing the virtual consent/baseline visit and the virtual education visit.
Treatment:
Behavioral: Self-Administered White Noise Hypnosis

Trial contacts and locations

1

Loading...

Central trial contact

Carrie K Lafferty, PhD; Noel M Arring, DNP, PhD, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems